A PET detector based on plastic scintillators offers whole-body imaging in addition to precision tests of fundamental symmetries.
New-Zealand company MARS Bioimaging Ltd has used technology developed at CERN to perform the first colour 3D X-ray of a human body, offering more accurate medical diagnoses.
The high-luminosity LHC promises a quantifiable return to society in terms of scientific, economic and cultural value.
The Big Science Business Forum (BSBF), held in Copenhagen, Denmark, saw delegates discuss opportunities in the current big-science landscape
The first annual knowledge-transfer thematic forum on medical applications takes place at CERN
Global healthcare company Novartis has announced plans to acquire Advanced Accelerator Applications (AAA), a spin-off radiopharmaceutical firm established by former CERN physicist Stefano Buono in 200...
Targeting linacs for new hadron-therapy treatment modes
CERN-MEDICIS has produced its first radioisotopes for medical research
Proton and ion therapy set to transform global cancer treatment
Working towards medical linacs for challenging environments